Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors-Reference-Cited by-同舟云学术

Optimization of the in Vitro Cardiac Safety of Hydroxamate-Based Histone Deacetylase Inhibitors

Published:2011-06-17 Issue:13 Volume:54 Page:4752-4772
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shultz Michael D.¹,Cao Xueying¹,Chen Christine H.¹,Cho Young Shin¹,Davis Nicole R.¹,Eckman Joe¹,Fan Jianmei¹,Fekete Alex¹,Firestone Brant¹,Flynn Julie¹,Green Jack¹,Growney Joseph D.¹,Holmqvist Mats¹,Hsu Meier¹,Jansson Daniel¹,Jiang Lei¹,Kwon Paul¹,Liu Gang¹,Lombardo Franco¹,Lu Qiang¹,Majumdar Dyuti¹,Meta Christopher¹,Perez Lawrence¹,Pu Minying¹,Ramsey Tim¹,Remiszewski Stacy¹,Skolnik Suzanne¹,Traebert Martin¹,Urban Laszlo¹,Uttamsingh Vinita¹,Wang Ping¹,Whitebread Steven¹,Whitehead Lewis¹,Yan-Neale Yan¹,Yao Yung-Mae¹,Zhou Liping¹,Atadja Peter¹

Affiliation:

1. Novartis Institutes for Biomedical Research, Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm200388e

Reference70 articles.

1. Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity

2. The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology

3. Acetylated NPM1 Localizes in the Nucleoplasm and Regulates Transcriptional Activation of Genes Implicated in Oral Cancer Manifestation